UPDATE | March 31, 2025

Reliable partnership for timely drug approvals

  • MAIL

Reliable partnership for timely drug approvals


Navigating the IND phase requires precision, expertise, and collaboration. Taeheui Lee, VP at Samsung Biologics, shares how CDMOs play a key role in accelerating drug development with tailored CMC strategies, scalable production, and expertise in regulatory compliance—all while ensuring safety and efficacy.


Discover how Samsung Biologics empowers drug developers with advanced technologies and a quality mindset to meet evolving industry demands.


Read More

Reliable partnership for timely drug approvals


Navigating the IND phase requires precision, expertise, and collaboration. Taeheui Lee, VP at Samsung Biologics, shares how CDMOs play a key role in accelerating drug development with tailored CMC strategies, scalable production, and expertise in regulatory compliance—all while ensuring safety and efficacy.


Discover how Samsung Biologics empowers drug developers with advanced technologies and a quality mindset to meet evolving industry demands.


Read More

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required